Decreased cell viability and ROS production induced by oxidative treatment. by Sandra M. Martín-Guerrero (780940)

AICAR-activated AMPK decreased SREBP-2 protein levels. by Shudong Liu (733425)

Islet proliferation decreases in high fat diet-fed mice. by Patricia de Godoy Bueno (731717)

Lethal toxin decreases IL-22 production in human ILCs. by Sudarshan Seshadri (370894)

ACE2 Is Augmented in Dystrophic Skeletal Muscle and Plays a Role in Decreasing Associated Fibrosis by Cecilia Riquelme (546116)

Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to... by Ming-Ling Chang (44638)

“…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …”

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

Lower signal-to-noise ratio leads to decreased peak assignment. by Travis S. Hughes (779495)

inhibition of autophagosome formation decreased the apoptosis induced by EV71. by Xueyan Xi (5654083)

Acupuncture decreases the level of p-c-Jun after SCI. by Jee Y. Lee (455790)

ORC2 knock-down decreases cellular DNA synthesis. by Tamara Evans Braun (166141)

c-Abl inhibition decreases ABCB1 expression and activity. by Jonathan T. Sims (278652)

CDDO-Me radioprotection decreases with progressive oncogenic manipulations in HBECs and in a matched NSCLC line. by Mariam El-Ashmawy (678638)

“…Immortalized HBECs with (A) lenti-<i>KRas</i>^V12, (B) lenti-<i>KRas</i>^V12 and sh<i>p53</i> knockdown, and (C) lenti-<i>KRas</i>^V12, sh<i>p53</i>, and <i>myc</i> overexpression. …”

Over time, melanization decreases with aging, higher temperature, and infection. by Lindsay E. Martin (17377067)

Increasing the diversity of host resistance decreases the probability of evolutionary emergence. by Hélène Chabas (3194250)

Fig 5 - by Thiago Bezerra Wanderley e Lima (14232350)

Grb2 silencing decreases phagocytic uptake in RPE cells. by Shameka J. Shelby (279119)

Foxa1 up-regulates UCP1 and decreases MMP. by Marta Moya (188959)

Absence of FumC leads to decreased susceptibility to bactericidal antibiotics. by Stephanie D. Himpsl (8501868)